President Trump on Tuesday announced that Pfizer had agreed to sell its products in the U.S. at "Most Favored Nation" pricing, one day after the administration required companies to respond to his prescription drug pricing executive order.

Drugmakers were given until Sept. 29 to respond to Trump's "Most Favored Nation" Executive Order that required companies sell drugs in the U.S. at the lowest price they sell in other developed countries, establish direct-to-consumer avenues and........

© The Hill